Matthew J. D'Onofrio, Executive VP, Chief Business Officer at Evoke Pharma Inc (EVOK), sold 86,357 shares at $2.91 ($252K) on 2020-12-11, disclosed to the SEC on 2020-12-14.
Open-market sale of $252k EVOK by Executive VP, Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.95 | 5,643 | $17K | 6.6% |
| 2 | $2.91 | 40,357 | $117K | 46.7% |
| 3 | $2.91 | 40,357 | $117K | 46.7% |
| Total | $2.91 avg | 86,357 | $252K | 100% |